January 29, 2018

ALEXANDRIA, Va. – Co-sponsors of the 2018 Cancer Survivorship Symposium announced today five abstracts that will be highlighted in the meeting’s official Press Program. Researchers will present the findings of these studies in an embargoed presscast for reporters, taking place Monday, February 12, 2018, from 12:00 noon – 1:30 p.m. ET.

The following studies will be featured during the presscast:

January 24, 2018

The American Society of Clinical Oncology (ASCO) congratulates Alex Azar for his confirmation as Secretary of the U.S. Department of Health and Human Services (HHS). As the head of HHS, Secretary Azar has an opportunity to help address critical issues facing the cancer care delivery system, including increasing access to high-quality care, addressing the high cost of care, and supporting the development and dissemination of innovative treatments

January 23, 2018

ALEXANDRIA, Va. — CancerLinQ LLC and the American College of Medical Genetics and Genomics (ACMG), the medical specialty society for clinical and laboratory genetics professionals, have entered into a programmatic collaboration. CancerLinQ®, the American Society of Clinical Oncology’s (ASCO) health information technology platform designed by oncologists for oncologists to leverage the power of big data to help improve the quality of care for patients with cancer, will benefit from the knowledge and expertise of ACMG leadership and members.

January 22, 2018

SAN FRANCISCO – Eight noteworthy studies exploring the implications of immuno-oncology for patient care will be presented at the 2018 ASCO-SITC Clinical Immuno-Oncology Symposium. The meeting will take place January 25-27 at the San Francisco Marriott Marquis in San Francisco, California. These notable abstracts discuss the efficacy of immunotherapy in rare cancers, biomarkers to predict which patients will benefit most, and managing the adverse effects of immune-based treatments.

January 18, 2018

ALEXANDRIA, Va. —  A registry that tracks the quality of medical care provided to patients receiving cancer treatment launched this month as part of a collaboration between the American Society of Clinical Oncology (ASCO) and the American Society for Radiation Oncology (ASTRO). In addition to improving the quality of care for people living with cancer, the Quality Oncology Practice Initiative (QOPI®) Reporting Registry also makes it easier for medical and radiation oncologists to report quality-related performance metrics required by the federal government.

January 17, 2018

Alexandria, Va.—CancerLinQ LLC and the Association for Molecular Pathology (AMP), a global, molecular diagnostics professional society, have entered into a collaboration. AMP leadership and members will be applying the breadth of their knowledge to CancerLinQ®, the American Society of Clinical Oncology’s (ASCO) health information technology platform designed to leverage the power of big data to help conquer cancer.

January 16, 2018

ALEXANDRIA, Va. – A new study has found that a test that identifies circulating tumor cells (CTCs) present in the bloodstream can detect colorectal cancer at an early stage, with accuracy ranging from 84 to 88%. Most prior studies using CTCs have been able to detect late-stage colorectal cancer, and this study is one of the first clinical studies to show that CTCs can be useful for detecting early, more treatable stages of the cancer. These findings will be presented at the upcoming 2018 ASCO Gastrointestinal Cancers Symposium in San Francisco, California.

January 12, 2018

ALEXANDRIA, Va. – Co-sponsors of the 2018 Genitourinary Cancers Symposium announced today four abstracts to be highlighted in the meeting’s official Press Program. Researchers will present the findings of these studies in an embargoed presscast for reporters, taking place Monday, February 5, 2018, from 12:00 noon – 1:30 p.m. ET.

January 10, 2018

ALEXANDRIA, Va. — CancerLinQ LLC and the National Society of Genetic Counselors (NSGC), the professional society for genetic counselors, announced today that they have entered into a strategic alliance. With the collaboration, NSGC leaders and members will provide expertise to CancerLinQ®, the American Society of Clinical Oncology’s (ASCO) health information technology platform aimed at improving the quality of cancer care using real-world cancer data.

December 21, 2017

ALEXANDRIA, Va. —  CancerLinQ LLC and the data services companies Tempus and Precision HealthAI announced today they have entered into an agreement that will accelerate development and delivery of high-quality, de-identified clinical databases for use by CancerLinQ®, its oncologist subscribers, partners, and the broader cancer community. The agreement will also enable CancerLinQ to more quickly build and expand on its core data sharing and quality improvement platform for oncology practices, and facilitate Tempus’ and Precision HealthAI’s connection to industry to support faster and better development of new treatments for patients. 

December 21, 2017

With the Tax Cuts and Jobs Act on the verge of being signed into law, the American Society of Clinical Oncology (ASCO) is concerned about across-the-board cuts to Medicare that the measure will trigger. We urge Congress to protect Medicare beneficiaries with cancer and other medical conditions by passing additional legislation to avoid cuts to the program.

December 19, 2017

Howard A. “Skip” Burris III, MD, FACP, FASCO, a long-time member and volunteer, has been elected to serve as the President of the American Society of Clinical Oncology (ASCO) for the term beginning in June 2019. Additionally, five members were elected to open seats on the ASCO Board of Directors, as well as two members to the ASCO Nominating Committee.

December 12, 2017

ALEXANDRIA, Va. --  CancerLinQ LLC and DIA, (Drug Information Association), a global nonprofit association of health care product development professionals, announced today that they have entered into a programmatic partnership. Under the agreement, DIA will offer the scientific expertise of its members from the life sciences industry to help inform CancerLinQ’s development and rollout. CancerLinQ® is ASCO’s health information technology platform, developed by oncologists for oncologists, aimed at enhancing and improving the understanding and treatment of cancer.

December 1, 2017

We are deeply concerned about the sequestration cuts that would be triggered by passage of the Tax Cuts and Jobs Act. The core mission of the American Society of Clinical Oncology (ASCO) is to ensure that cancer patients have meaningful access to high-quality cancer care. We fear that the current proposal will harm patients with cancer by reducing access to care, a situation that could adversely impact treatment needed to extend and save patients' lives.

November 30, 2017

A report released today by the National Academies of Sciences, Engineering, and Medicine underscores the imperative our nation faces to address the affordability of drugs for medical conditions that have long-been deemed untreatable. Nowhere is this imperative more urgent than with the new generation of cancer drugs that is giving hope to the millions of Americans who face a cancer diagnosis each year--while creating formidable barriers to access due to the high cost of these agents.

Pages